BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35403742)

  • 21. Molecular confirmation of t(6;11)(p21;q12) renal cell carcinoma in archival paraffin-embedded material using a break-apart TFEB FISH assay expands its clinicopathologic spectrum.
    Argani P; Yonescu R; Morsberger L; Morris K; Netto GJ; Smith N; Gonzalez N; Illei PB; Ladanyi M; Griffin CA
    Am J Surg Pathol; 2012 Oct; 36(10):1516-26. PubMed ID: 22892601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Eosinophilic Solid and Cystic Renal Cell Carcinoma With Melanin Pigment-Expanding the Morphological Spectrum.
    Aldera AP; Hes O
    Int J Surg Pathol; 2022 May; 30(3):295-299. PubMed ID: 34402332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TSC loss is a clonal event in eosinophilic solid and cystic renal cell carcinoma: a multiregional tumor sampling study.
    Munari E; Settanni G; Caliò A; Segala D; Lonardi S; Sandrini S; Vacca P; Tumino N; Marconi M; Brunelli M; Gobbo S; Netto GJ; Moretta L; Zamboni G; Martignoni G
    Mod Pathol; 2022 Mar; 35(3):376-385. PubMed ID: 33990704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic utility of one-stop fusion gene panel to detect TFE3/TFEB gene rearrangement and amplification in renal cell carcinomas.
    Harada S; Caliò A; Janowski KM; Morlote D; Rodriguez Pena MD; Canete-Portillo S; Harbi D; DeFrank G; Magi-Galluzzi C; Netto GJ; Martignoni G; Mackinnon AC
    Mod Pathol; 2021 Nov; 34(11):2055-2063. PubMed ID: 34148064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Are Sporadic Eosinophilic Solid and Cystic Renal Cell Carcinomas Characterized by Somatic Tuberous Sclerosis Gene Mutations?
    Parilla M; Kadri S; Patil SA; Ritterhouse L; Segal J; Henriksen KJ; Antic T
    Am J Surg Pathol; 2018 Jul; 42(7):911-917. PubMed ID: 29668487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TFEB Rearranged Renal Cell Carcinoma: Pathological and Molecular Characterization of 10 Cases, with Novel Clinical Implications: A Single Center 10-Year Experience.
    Wang AX; Tian T; Liu LB; Yang F; He HY; Zhou LQ
    Biomedicines; 2023 Jan; 11(2):. PubMed ID: 36830782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognosis and Clinicopathological Characters of Adult TFEB-Altered Renal Cell Carcinoma: A Single Center Experience of 18 Cases.
    Wu J; Cao CZ; Cui HL; Du G; Shi HZ; Liang J; Guo L; Wang YC; Zhang J; Zhou AP; Li CL; Zheng S; Shou JZ
    Clin Genitourin Cancer; 2024 Apr; 22(2):261-268.e3. PubMed ID: 38104031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review of TFEB-amplified renal cell carcinoma with focus on clinical and pathobiological aspects.
    Kuroda N; Sugawara E; Ohe C; Kojima F; Ohashi R; Mikami S; Nagashima Y; Peckova K; Michal M; Hes O
    Pol J Pathol; 2021; 72(3):197-199. PubMed ID: 35048631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eosinophilic, Solid, and Cystic Renal Cell Carcinoma: Clinicopathologic Study of 16 Unique, Sporadic Neoplasms Occurring in Women.
    Trpkov K; Hes O; Bonert M; Lopez JI; Bonsib SM; Nesi G; Comperat E; Sibony M; Berney DM; Martinek P; Bulimbasic S; Suster S; Sangoi A; Yilmaz A; Higgins JP; Zhou M; Gill AJ; Przybycin CG; Magi-Galluzzi C; McKenney JK
    Am J Surg Pathol; 2016 Jan; 40(1):60-71. PubMed ID: 26414221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aggressive and nonaggressive translocation t(6;11) renal cell carcinoma: comparative study of 6 cases and review of the literature.
    Peckova K; Vanecek T; Martinek P; Spagnolo D; Kuroda N; Brunelli M; Vranic S; Djuricic S; Rotterova P; Daum O; Kokoskova B; Vesela P; Pivovarcikova K; Bauleth K; Dubova M; Kalusova K; Hora M; Michal M; Hes O
    Ann Diagn Pathol; 2014 Dec; 18(6):351-7. PubMed ID: 25438924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. "Oncocytoid Renal Cell Carcinomas After Neuroblastoma" Represent TSC -mutated Eosinophilic Solid and Cystic Renal Cell Carcinomas : Association With Prior Childhood Malignancy and Multifocality With Therapeutic Implications.
    Argani P; Medeiros LJ; Matoso A; Baraban E; Lotan T; Pawel BR; McKenney JK; Mehra R; Falzarano SM; Pallavajjalla A; Lin MT; Patel S; Rawwas J; Bendel AE; Gagan J; Palsgrove DN
    Am J Surg Pathol; 2023 Dec; 47(12):1335-1348. PubMed ID: 37522346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of 6 TFEB-amplified renal cell carcinomas and 25 renal cell carcinomas with MITF translocations: systematic morphologic analysis of 85 cases evaluated by clinical TFE3 and TFEB FISH assays.
    Skala SL; Xiao H; Udager AM; Dhanasekaran SM; Shukla S; Zhang Y; Landau C; Shao L; Roulston D; Wang L; Siddiqui J; Cao X; Magi-Galluzzi C; Zhang M; Osunkoya AO; Smith SC; McKenney JK; Betz BL; Myers JL; Chinnaiyan AM; Tomlins SA; Mehra R
    Mod Pathol; 2018 Jan; 31(1):179-197. PubMed ID: 28840857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diverse fusion patterns and heterogeneous clinicopathologic features of renal cell carcinoma with t(6;11) translocation.
    Inamura K; Fujiwara M; Togashi Y; Nomura K; Mukai H; Fujii Y; Yamamoto S; Yonese J; Fukui I; Ishikawa Y
    Am J Surg Pathol; 2012 Jan; 36(1):35-42. PubMed ID: 22173116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiT family translocation renal cell carcinoma.
    Argani P
    Semin Diagn Pathol; 2015 Mar; 32(2):103-13. PubMed ID: 25758327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TFEB rearranged renal cell carcinoma. A clinicopathologic and molecular study of 13 cases. Tumors harboring MALAT1-TFEB, ACTB-TFEB, and the novel NEAT1-TFEB translocations constantly express PDL1.
    Caliò A; Harada S; Brunelli M; Pedron S; Segala D; Portillo SC; Magi-Galluzzi C; Netto GJ; Mackinnon AC; Martignoni G
    Mod Pathol; 2021 Apr; 34(4):842-850. PubMed ID: 33208882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GPNMB expression identifies TSC1/2/mTOR-associated and MiT family translocation-driven renal neoplasms.
    Salles DC; Asrani K; Woo J; Vidotto T; Liu HB; Vidal I; Matoso A; Netto GJ; Argani P; Lotan TL
    J Pathol; 2022 Jun; 257(2):158-171. PubMed ID: 35072947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Re-evaluation of 33 'unclassified' eosinophilic renal cell carcinomas in young patients.
    Li Y; Reuter VE; Matoso A; Netto GJ; Epstein JI; Argani P
    Histopathology; 2018 Mar; 72(4):588-600. PubMed ID: 28898443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. VEGFA amplification/increased gene copy number and VEGFA mRNA expression in renal cell carcinoma with TFEB gene alterations.
    Caliò A; Brunelli M; Segala D; Pedron S; Doglioni C; Argani P; Martignoni G
    Mod Pathol; 2019 Feb; 32(2):258-268. PubMed ID: 30206412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Eosinophilic solid and cystic renal cell carcinoma mimicking epithelioid angiomyolipoma: series of 4 primary tumors and 2 metastases.
    Tretiakova MS
    Hum Pathol; 2018 Oct; 80():65-75. PubMed ID: 29885406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Tale of 2 Morphologies: Diagnostic Pitfalls in
    Sharma AE; Parilla M; Wanjari P; Segal JP; Antic T
    Int J Surg Pathol; 2021 Feb; 29(1):21-29. PubMed ID: 32886007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.